STOCKHOLDERS’ EQUITY (DEFICIENCY) (Details Narrative) - USD ($)					3 Months Ended						9 Months Ended		12 Months Ended
	Dec. 21, 2021	May 22, 2020	Jan. 09, 2020	Feb. 02, 2016	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Dec. 31, 2022	Dec. 31, 2021	Mar. 31, 2022	Mar. 31, 2020	Dec. 21, 2022
Class of Stock [Line Items]
Common Stock, Shares Authorized					125,000,000						125,000,000		125,000,000
Common Stock, Par or Stated Value Per Share													$ 0.001
Preferred Stock, Shares Authorized					10,000,000						10,000,000		10,000,000
Preferred Stock, Par or Stated Value Per Share													$ 0.001
Common Stock, Shares, Issued					50,775,354						50,775,354		49,810,322
Common Stock, Other Shares, Outstanding					1,466,718						1,466,718		1,466,718
Preferred Stock, Shares Outstanding													1
Debt Instrument, Redemption Price, Percentage											110.00%
Repayments of Debt											$ 20,264
Stock Issued During Period, Value, New Issues												$ 250,000
Stock Issued During Period, Shares, Issued for Services					105,263	22,772	4,167						250,000
Stock Issued During Period, Value, Issued for Services					$ 112,631	$ 30,287	$ 7,500	$ 142,501			150,418	967,092	$ 1,414,449
Proceeds from Issuance of Preferred Stock and Preference Stock												100,000
Proceeds from Issuance of Common Stock												250,000
[custom:StockIssuedDuringPeriodSharesNewIssuesIntoAdditionalPaidInCapital]											100,094
[custom:StockIssuedDuringPeriodValueNewIssuesIntoAdditionalPaidInCapital]											$ 77,300
Proceeds from Warrant Exercises											$ 12,500	518,964
Fair Value Adjustment of Warrants	$ 1,042,149
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right					306,604						306,604				57,536
Share-Based Payment Arrangement, Noncash Expense											$ 365,653	$ 426,280
2016 Equity Incentive Plan [Member]
Class of Stock [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized				3,750,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term														10 years
Share Price														$ 0.974
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate														132.20%
Shares Issued, Value, Share-Based Payment Arrangement, before Forfeiture														$ 1,600,515
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross						3,757	10,180
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term						10 years	10 years
Share-Based Payment Arrangement, Noncash Expense						$ 153,338	$ 149,190		$ 169,778	$ 155,851
Share-Based Payment Arrangement, Expense					$ 63,125			$ 100,650
General and Administrative Expense [Member]
Class of Stock [Line Items]
Fair Value Adjustment of Warrants													$ 541,443
Warrants and Rights Outstanding					$ 77,780	$ 77,332	$ 77,414				77,780
Minimum [Member]
Class of Stock [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price													$ 2.40
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term													2 years
Minimum [Member] | 2016 Equity Incentive Plan [Member]
Class of Stock [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate														0.46%
Maximum [Member]
Class of Stock [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price													$ 3.98
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term													10 years
Maximum [Member] | 2016 Equity Incentive Plan [Member]
Class of Stock [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate														0.75%
Uplisting Public Stock Offering [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues													5,382,331
Proceeds from Issuance of Common Stock													$ 14,545,805
Convertible Promissory Notes [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues					238,846
Number of stock issued during the period convertible, shares						117,647	404,545						4,696,083
Stock Issued During Period, Shares, Conversion of Convertible Securities													19,263
Repayments of Debt													$ 14,522,812
Convertible Notes Payable					$ 153,600	$ 100,000	$ 302,000				153,600		10,309,000
Debt Instrument, Convertible, Beneficial Conversion Feature					53,402	35,274	104,118						3,398,557
Unpaid interest amount													815,255
Stock Issued During Period, Value, New Issues													15,678,454
[custom:StockIssuedDuringPeriodValueToBeIssued]													$ 1,155,642
[custom:DebtsInstrumentSettlementAmount]					207,002	135,274	406,118
Debt Instrument, Fair Value Disclosure					211,602	175,294	457,025				$ 211,602
Loss on conversion of convertible promissory notes					4,600	$ 40,020	$ 50,908
Warrant [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues													658,355
Stock Issued During Period, Shares, Issued for Services											312,500		451,688
[custom:StockIssuedDuringPeriodSharesWarrantsExercised]							11,792
[custom:StockIssuedDuringPeriodValueWarrantsExercise]							$ 12,500
Class of Warrant or Right, Outstanding													658,355
Cash receipt amount													$ 872,292
[custom:ClassOfWarrantOrRightCashlessWarrantExercise-0]													446,370
Proceeds from Warrant Exercises													$ 103,950
Warrants and Rights Outstanding					$ 71,768						$ 71,768
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right					306,604						306,604
Cashless Warrant [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues													446,370
Shares To Be Issued [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, Conversion of Convertible Securities												602,059	69,252
Stock Issued During Period, Value, New Issues
Stock Issued During Period, Shares, Issued for Services								(81,522)
Stock Issued During Period, Value, Issued for Services								$ (255,979)
Proceeds from Issuance of Preferred Stock and Preference Stock													$ 250,000
[custom:StockIssuedDuringPeriodSharesWarrantsExercised]								11,792			(100,094)	73,112
Issuance of Common Shares [Member]
Class of Stock [Line Items]
[custom:NumberSharesRemovedPreviouslyToBeIssued]							40,094
Issuance of Common Shares [Member] | Minimum [Member]
Class of Stock [Line Items]
Shares Issued, Value, Share-Based Payment Arrangement, Forfeited							$ 42,500
Exchange Agreement [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues				13,376,947
Exchange Agreement [Member] | 11% Secured Convertible Promissory Notes [Member]
Class of Stock [Line Items]
Conversion of Stock, Description				The outstanding 11% secured convertible promissory notes of iMedical were adjusted, in accordance with the adjustment provisions thereof, as and from closing, so as to permit the holders to convert (and in some circumstances permit the Company to force the conversion of) the convertible promissory notes into shares of the common stock of the Company at a
Discount percentage for purchase price per shares				25.00%
Exchange Agreement [Member] | Warrant [Member]
Class of Stock [Line Items]
Common stock exchange description				Each outstanding warrant to purchase common shares in iMedical was adjusted, in accordance with the terms thereof, such that it entitles the holder to receive approximately 1.197 shares of the common stock of the Company for each warrant, with an inverse adjustment to the exercise price of the warrants to reflect the exchange ratio of approximately 1.197:1
Exchange Agreement [Member] | Advisor Warrant [Member]
Class of Stock [Line Items]
Common stock exchange description				Each outstanding advisor warrant to purchase common shares in iMedical was adjusted, in accordance with the terms thereof, such that it entitles the holder to receive approximately 1.197 shares of the common stock of the Company for each advisor warrant, with an inverse adjustment to the exercise price of the Advisor Warrants to reflect the exchange ratio of approximately 1.197:1; and
Exchange Agreement [Member] | Options [Member]
Class of Stock [Line Items]
Common stock exchange description				Each outstanding option to purchase common shares in iMedical (whether vested or unvested) was exchanged, without any further action or consideration on the part of the holder of such option, for approximately 1.197 economically equivalent replacement options with an inverse adjustment to the exercise price of the replacement option to reflect the exchange ratio of approximately 1.197:1
Shareholders [Member] | Exchange Agreement [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues											52,242,072		51,277,040
Common stock exchange description				The Company issued approximately 1.197 shares of its common stock in exchange for each common share of iMedical held by the iMedical shareholders who in general terms, are not residents of Canada (for the purposes of the Income Tax Act (Canada)
Exchangeco [Member] | Exchange Agreement [Member]
Class of Stock [Line Items]
Common stock exchange description				Shareholders of iMedical who in general terms, are Canadian residents (for the purposes of the Income Tax Act (Canada)) received approximately 1.197 Exchangeable Shares in the capital of Exchangeco in exchange for each common share of iMedical held. Accordingly, the Company issued
[custom:NumberOfExchangeableSharesIssued]				9,123,031
Investors [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues													1,423,260
Advisor and Consultant [Member]
Class of Stock [Line Items]
Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture													25,000
Advisor and Consultant [Member] | Warrant [Member]
Class of Stock [Line Items]
Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture													212,594
Executive Officer [Member] | Warrant [Member]
Class of Stock [Line Items]
Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture													187,594
Lenders [Member] | Warrant [Member]
Class of Stock [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights													57,536
Warrants and Rights Outstanding													$ 198,713
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpirationDate]													Dec. 21, 2028
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price													$ 6.26
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate													1.40%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate													121.71%
Underwriter [Member] | Warrant [Member]
Class of Stock [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights													373,404
Warrants and Rights Outstanding													$ 900,371
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpirationDate]													Aug. 26, 2026
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price													$ 3.75
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate													0.77%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate													111.90%
Executive [Member] | Warrant [Member]
Class of Stock [Line Items]
Stock Issued During Period, Shares, New Issues					218,785	118,282	53,827
Employee [Member] | 2016 Equity Incentive Plan [Member]
Class of Stock [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term											10 years			3 years
Board of Director [Member] | 2016 Equity Incentive Plan [Member]
Class of Stock [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term														10 years
Series A Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Shares Authorized													20,000
Preferred Stock, Par or Stated Value Per Share					$ 0.001						$ 0.001		$ 0.001
Stock Issued During Period, Shares, New Issues			6,000						100				288,756
Preferred Stock, Shares Outstanding					6,305						6,305		7,201
Preferred Stock, Liquidation Preference Per Share					$ 1,000						$ 1,000
Preferred Stock, Dividend Rate, Percentage											12.00%
Debt Instrument, Redemption Price, Percentage											5.00%
Preferred Stock, Convertible, Conversion Price					$ 0.001						$ 0.001
[custom:VolumeWeightedAveragePricePercentage]											15.00%
Convertible Notes Payable					$ 200,000						$ 200,000
Proceeds from Issuance of Preferred Stock and Preference Stock		$ 100,000	$ 6,000,000						$ 100,000				$ 100,000
Issuance of preferred shares for private placement investors shares													100